Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 117,12
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 146,15
Quantità: Più di 20 disponibili
Aggiungi al carrelloPaperback. Condizione: New. Softcover reprint of the original 1st ed. 1999.
EUR 137,73
Quantità: Più di 20 disponibili
Aggiungi al carrelloPaperback. Condizione: New. Softcover reprint of the original 1st ed. 1999.
EUR 162,51
Quantità: Più di 20 disponibili
Aggiungi al carrelloKartoniert / Broschiert. Condizione: New.
Condizione: New.
EUR 167,00
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Proton Pump Inhibitors | Lars Olbe | Taschenbuch | x | Englisch | 2013 | Birkhäuser | EAN 9783034897778 | Verantwortliche Person für die EU: Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
EUR 229,68
Quantità: 15 disponibili
Aggiungi al carrelloCondizione: New. Editor(s): Olbe, Lars. Series: Milestones in Drug Therapy. Num Pages: 261 pages, biography. BIC Classification: MB. Category: (P) Professional & Vocational. Dimension: 244 x 170 x 14. Weight in Grams: 467. . 2013. 1999th Edition. paperback. . . . .
Condizione: New. pp. 268.
EUR 230,90
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Like New. Like New. book.
Lingua: Inglese
Editore: Birkhäuser Basel, Birkhäuser Basel, 2013
ISBN 10: 3034897774 ISBN 13: 9783034897778
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 192,59
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Inhibition of the proton pump in the parietal cells has been established as the main therapeutic principle in the treatment of acid-related diseases, such as peptic ulcer and gastro-oesophageal reflux. The proton pump inhi bitors are tailored for their purpose. They accumulate in the target cell, are activated by acid and bind strongly to the specific target - the proton pump. The clinical superiority of the proton pump inhibitors is due not only to their high efficacy but also to the long duration of the acid inhibition in comparison with other antisecretory drugs. At present when drug discovery mostly relies on identification and characterization of potential targets by genome research, molecular biology, combinatorial chemistry and automated screening, it seems worthwhile to present the development of the tITst proton pump inhibitor - omeprazol- starting from a chemical structure with an observed antisecretory effect but also severe toxic effects that had to be eliminated. As always, basic and applied research operate luind in hand to optimize the delicate balance be tween efficacy and safety of a new drug. This goal often involves time and many different specialists.
Condizione: As New. Unread book in perfect condition.
EUR 278,14
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 1999 edition. 268 pages. 9.60x6.69x0.61 inches. In Stock.
Condizione: New. Editor(s): Olbe, Lars. Series: Milestones in Drug Therapy. Num Pages: 261 pages, biography. BIC Classification: MB. Category: (P) Professional & Vocational. Dimension: 244 x 170 x 14. Weight in Grams: 467. . 2013. 1999th Edition. paperback. . . . . Books ship from the US and Ireland.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 150,28
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Springer, Basel, Birkhäuser Basel, Birkhäuser Okt 2013, 2013
ISBN 10: 3034897774 ISBN 13: 9783034897778
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 192,59
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Inhibition of the proton pump in the parietal cells has been established as the main therapeutic principle in the treatment of acid-related diseases, such as peptic ulcer and gastro-oesophageal reflux. The proton pump inhi bitors are tailored for their purpose. They accumulate in the target cell, are activated by acid and bind strongly to the specific target - the proton pump. The clinical superiority of the proton pump inhibitors is due not only to their high efficacy but also to the long duration of the acid inhibition in comparison with other antisecretory drugs. At present when drug discovery mostly relies on identification and characterization of potential targets by genome research, molecular biology, combinatorial chemistry and automated screening, it seems worthwhile to present the development of the tITst proton pump inhibitor - omeprazol- starting from a chemical structure with an observed antisecretory effect but also severe toxic effects that had to be eliminated. As always, basic and applied research operate luind in hand to optimize the delicate balance be tween efficacy and safety of a new drug. This goal often involves time and many different specialists. 251 pp. Englisch.
Lingua: Inglese
Editore: Birkhäuser Basel, Birkhäuser Okt 2013, 2013
ISBN 10: 3034897774 ISBN 13: 9783034897778
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 192,59
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Inhibition of the proton pump in the parietal cells has been established as the main therapeutic principle in the treatment of acid-related diseases, such as peptic ulcer and gastro-oesophageal reflux. The proton pump inhi bitors are tailored for their purpose. They accumulate in the target cell, are activated by acid and bind strongly to the specific target - the proton pump. The clinical superiority of the proton pump inhibitors is due not only to their high efficacy but also to the long duration of the acid inhibition in comparison with other antisecretory drugs. At present when drug discovery mostly relies on identification and characterization of potential targets by genome research, molecular biology, combinatorial chemistry and automated screening, it seems worthwhile to present the development of the tITst proton pump inhibitor - omeprazol- starting from a chemical structure with an observed antisecretory effect but also severe toxic effects that had to be eliminated. As always, basic and applied research operate luind in hand to optimize the delicate balance be tween efficacy and safety of a new drug. This goal often involves time and many different specialists.Springer Nature c/o IBS, Benzstrasse 21, 48619 Heek 268 pp. Englisch.
Da: Majestic Books, Hounslow, Regno Unito
EUR 271,90
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 268 51 Illus.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 271,97
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND pp. 268.